Meet Dr. Mary E. Brunkow, who made headlines with her unexpected Nobel Prize win for her contributions to medicine.

It feels counterintuitive that the U.S. Food and Drug Administration would refuse to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology.

The Wiley Foundation honored research into connectomes — detailed atlases of the brain that map out thousands of neurons and the millions of connection between them.

Shinya Yamanaka, a Nobel laureate, did not follow a typical path to success. His curiosity and persistence led to a ...

With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.

LOS ANGELES, CA / ACCESS Newswire / February 13, 2026 / Nature Cell, led by Chairman Jeong-Chan Ra and specializing in adult stem cell biotechnology, announced that its U.S. subsidiary, Nature Cell ...

Last month, I travelled across India, listening, observing, and taking stock. While the journey was energising and often in ...

Explore the journey of Payam Khastkhodaei and his innovative approach to piano teaching that has captivated nearly 500 ...

The FDA declined to review Moderna's mRNA influenza vaccine due to inadequate clinical trial comparators for older adults.

Aimee Donnellan has been a correspondent for Reuters since 2017. Her patch includes the pharmaceutical industry. Off the ...

Discover how Treg cell therapies rethink precision medicine for autoimmune diseases like type 1 diabetes, MS, and transplant rejection.

A year after he finished high school, Selman’s mother passed away – his main inspiration for all his successes. The father ...